Michael Miller
RX Communications
Replay available
ReShape Lifesciences, Inc. (RSLS) Q3 2023 Earnings Call
ReShape Lifesciences, Inc. (NASDAQ: RSLS) Q3 2023 earnings conference call, held 2023-11-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Paul Hickey
President and Chief Executive Officer, Reshape Life Sciences
Dr. Carolina Povian
Co-Director, Center for Weight Management and Wellness at Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School; Member, Scientific Advisory Board
Tom Stankovich
Chief Financial Officer, Reshape Life Sciences
Anthony Vendetti
Analyst, Maxim Group
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vyome Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.097 -- 00:00:04.459 Good afternoon, and thank you for joining the Reshape Life Sciences third quarter 2023 00:00:04.459 -- 00:00:09.821 conference call. I would now like to turn the call over to Michael Miller from 00:00:09.821 -- 00:00:12.102 RX Communications. 00:00:13.343 -- 00:00:17.485 Good afternoon, and thank you for joining the Reshape Life Sciences third quarter 2023 00:00:17.485 -- 00:00:22.587 earnings call. I'm pleased to be joined today by Paul Hickey, President and 00:00:22.587 -- 00:00:27.674 Chief Executive Officer, and Tom Stankovich, Chief Financial Officer. 00:00:27.674 -- 00:00:32.435 Paul will provide an overview and update on the company's activities, which will include 00:00:32.435 -- 00:00:37.476 a discussion with Dr. Carolina Povian, a member of Reshape's Scientific Advisory 00:00:37.476 -- 00:00:42.398 Board. Then Tom will review the financial results for the period. 00:00:42.398 -- 00:00:47.159 We'll then turn the call back over to Paul for some closing remarks, after which we'll 00:00:47.159 -- 00:00:50.899 open the call to a question and answer session. 00:00:50.960 -- 00:00:56.021 As a reminder, this conference call, as well as Reshape Life Sciences SEC 00:00:56.021 -- 00:01:01.444 filings, and website, including the investor information section of the website, contains 00:01:01.444 -- 00:01:05.827 forward-looking statements within the meaning of the Private Securities Litigation Reform 00:01:05.827 -- 00:01:07.849 Act of 1995. 00:01:07.849 -- 00:01:12.993 Actual results could differ materially from those discussed due to known and 00:01:12.993 -- 00:01:16.555 unknown risks, uncertainties, and other factors. 00:01:16.555 -- 00:01:21.199 These and additional risks and uncertainties are described more fully in the company's...